<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="In 2002, an outbreak of SARS was first reported in" exact="China" post="and then spread quickly worldwide, resulting in hundreds of"/>
 <result pre="11% mortality rate [3,4]. In 2012, MERS first emerged in" exact="Saudi Arabia" post="and subsequently spread to other countries, with a fatality"/>
 <result pre="human-to-human transmission. At present, the National Health Commission of the" exact="People's Republic of China" post="has recorded a total of 80 304 confirmed cases"/>
 <result pre="transmission. At present, the National Health Commission of the People's" exact="Republic of" post="China has recorded a total of 80 304 confirmed"/>
 <result pre="present, the National Health Commission of the People's Republic of" exact="China" post="has recorded a total of 80 304 confirmed cases"/>
 <result pre="observation. A total of 137 confirmed cases were reported from" exact="Macao" post="Special Administrative Region (SAR) (n = 10), Hong Kong"/>
 <result pre="reported from Macao Special Administrative Region (SAR) (n = 10)," exact="Hong Kong" post="SAR (n = 93) and Taiwan (Republic of China)"/>
 <result pre="(n = 10), Hong Kong SAR (n = 93) and" exact="Taiwan" post="(Republic of China) (n = 34). In addition to"/>
 <result pre="concomitant use of steroids during the outbreak of SARS in" exact="Hong Kong" post="[74], [75], [76]. Thus, ribavirin could be considered as"/>
 <result pre="antiviral drug against influenza infection that is widely used in" exact="Russia" post="and China. Arbidol and arbidol mesylate were shown to"/>
 <result pre="[79]. In addition, the first case of SARS-CoV-2 infection in" exact="the USA" post="was treated with intravenous remdesivir when the patient's condition"/>
 <result pre="been reported that a small number of SARS-CoV-infected patients in" exact="Taiwan" post="and Hong Kong received treatment with convalescent plasma during"/>
 <result pre="that a small number of SARS-CoV-infected patients in Taiwan and" exact="Hong Kong" post="received treatment with convalescent plasma during the early course"/>
 <result pre="of primary, household, and nosocomial transmissionLancet Infect Dis182018e217e22710.1016/S1473-3099(18)30127-029680581 7SuSWongGLiuYGaoGFLiSBiYMERS in" exact="South Korea" post="and China: a potential outbreak threat?Lancet38520152349235010.1016/S0140-6736(15)60859-526088634 8ReuskenCBHaagmansBLMüllerMAGutierrezCGodekeGJMeyerBMiddle East respiratory"/>
 <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci63202045746010.1007/s11427-020-1637-532009228 12WongJELLeoYSTanCCCOVID-19 in Singapore—current experience: critical global issues"/>
 <result pre="fatal case of Middle East respiratory syndrome coronavirus infection in" exact="the United Arab Emirates," post="April 2014Am J Pathol186201665265810.1016/j.ajpath.2015.10.02426857507 58ChungMBernheimAMeiXZhangNHuangMZengXCT imaging features of 2019"/>
 <result pre="case of Middle East respiratory syndrome coronavirus infection in the" exact="United Arab Emirates," post="April 2014Am J Pathol186201665265810.1016/j.ajpath.2015.10.02426857507 58ChungMBernheimAMeiXZhangNHuangMZengXCT imaging features of 2019"/>
 <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ Antimicrob Chemother56200591992210.1093/jac/dki34616183666 103ter MeulenJBakkerABvan den BrinkENWeverlingGJMartinaBEHaagmansBLHuman monoclonal antibody"/>
 <result pre="This work was supported by the Natural Science Foundation of" exact="China" post="[nos. 81570408 and 81770461]. Competing interests: None declared. Ethical"/>
</results>
